datamatters24/research-document-archive huggingface dataset:
I 
109TH CONGRESS 
1ST SESSION H. R. 2169 
To suspend temporarily the duty on Cohedur RL. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 5, 2005 
Mr. BROWN of South Carolina introduced the following bill; which was 
referred to the Committee on Ways and Means 
A BILL 
To suspend temporarily the duty on Cohedur RL. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. COHEDUR RL. 
(a) IN GENERAL.—Subchapter II of chapter 99 of 
the Harmonized Tariff Schedule of the United States is 
amended by inserting in numerical sequence the following 
new heading: 
‘‘ 
9902.06.08 
Mixtures of resorcinal, 
hexamethylolmelamine ether 
(CAS No. 3089–11–0) and 
dibutyl phthalate (CAS No. 
84–74–2)(provided for in 
subheading 3824.90.28) ......
Free 
No change 
No change 
On or before 
12/31/2009 
’’.
(b) EFFECTIVE DATE.—The amendment made by 
subsection (a) applies to goods entered, or withdrawn from 
warehouse for consumption, on or after the 15th day after 
the date of the enactment of this Act. 
Æ
174 
duties do not include making decisions on 
claims for benefits. 
‘‘(C) 
LIMITATION.—Subparagraph 
(A) 
does not apply in connection with any directed 
recordkeeper to the extent that the directed rec-
ordkeeper fails to follow the specific instruction 
of the plan or the employer or other plan spon-
sor. 
‘‘(16) EXCLUSION
OF
HEALTH
INSURANCE 
AGENTS.—Paragraph (1) does not apply with re-
spect to a person whose sole involvement with the 
group health plan is providing advice or administra-
tive services to the employer or other plan sponsor 
relating to the selection of health insurance coverage 
offered in connection with the plan. 
‘‘(17) NO EFFECT ON STATE LAW.—No provi-
sion of State law (as defined in section 514(c)(1)) 
shall be treated as superseded or otherwise altered, 
amended, modified, invalidated, or impaired by rea-
son of the provisions of subsection (a)(1)(C) and this 
subsection. 
‘‘(18) RELIEF FROM LIABILITY FOR EMPLOYER 
OR
OTHER
PLAN
SPONSOR
BY
MEANS
OF
DES-
IGNATED DECISIONMAKER.—
175 
‘‘(A) IN
GENERAL.—Notwithstanding the 
direct participation (as defined in paragraph 
(5)(C)(i)) of an employer or plan sponsor, in 
any case in which there is (or is deemed under 
subparagraph (B) to be) a designated decision-
maker under subparagraph (B) that meets the 
requirements of subsection (o)(1) for an em-
ployer or other plan sponsor— 
‘‘(i) all liability of such employer or 
plan sponsor involved (and any employee of 
such employer or sponsor acting within the 
scope of employment) under this sub-
section in connection with any participant 
or beneficiary shall be transferred to, and 
assumed by, the designated decisionmaker, 
and 
‘‘(ii) with respect to such liability, the 
designated decisionmaker shall be sub-
stituted for the employer or sponsor (or 
employee) in the action and may not raise 
any defense that the employer or sponsor 
(or employee) could not raise if such a de-
cisionmaker were not so deemed. 
‘‘(B) AUTOMATIC DESIGNATION.—A health 
insurance issuer shall be deemed to be a des-
I 
109TH CONGRESS 
1ST SESSION H. R. 1916 
To 
suspend 
temporarily 
the 
duty 
on 
5-Amino-1-[2,6-dichloro-4- 
(trifluoromethyl)phenyl]-4-[(1R,S)–(trifluoromethyl)-sulfiny 
]-1H-pyr-
azole-3-carbonitrile. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 27, 2005 
Mr. HULSHOF introduced the following bill; which was referred to the 
Committee on Ways and Means 
A BILL 
To suspend temporarily the duty on 5-Amino-1-[2,6-dichloro- 
4- 
(trifluoromethyl)phenyl]-4-[(1R,S)–(trifluoromethyl)- 
sulfiny ]-1H-pyrazole-3-carbonitrile. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 
1. 
5-AMINO-1-[2,6-DICHLORO-4- 
(TRIFLUOROMETHYL)PHENYL]-4-[(1R,S)– 
(TRIFLUOROMETHYL)-SULFINYL]-1H-PYR-
AZOLE-3-CARBONITRILE. 
(a) IN GENERAL.—Subchapter II of chapter 99 of 
the Harmonized Tariff Schedule of the United States is
amended by inserting in numerical sequence the following 
new heading: 
‘‘ 
9902.05.61 
5-Amino-1-[2,6-dichloro-4- 
(trifluoromethyl)phenyl]-4- 
[(1R,S)–(trifluoromethyl)- 
sulfinyl]-1H-pyrazole-3- 
carbonitrile (CAS No. 
120068–37–3) (provided for 
in subheading 2933.19.37) ..
Free 
No change 
No change 
On or before 
12/31/2008 
’’. 
(b) EFFECTIVE DATE.—The amendment made by 
subsection (a) applies to goods entered, or withdrawn from 
warehouse for consumption, on or after the 15th day after 
the date of enactment of this Act. 
Æ
I 
109TH CONGRESS 
1ST SESSION 
H. R. 216
To authorize the Secretary of Health and Human Services to make grants 
to nonprofit tax-exempt organizations for the purchase of ultrasound 
equipment to provide free examinations to pregnant women needing such 
services, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 4, 2005
Mr. STEARNS introduced the following bill; which was referred to the 
Committee on Energy and Commerce 
A BILL 
To authorize the Secretary of Health and Human Services 
to make grants to nonprofit tax-exempt organizations 
for the purchase of ultrasound equipment to provide 
free examinations to pregnant women needing such serv-
ices, and for other purposes.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Informed Choice Act’’.
SEC. 2. GRANTS FOR PURCHASE OF ULTRASOUND EQUIP-
MENT. 
(a) IN GENERAL.—The Secretary of Health and 
Human services may make grants for the purchase of 
ultrasound equipment. Such ultrasound equipment shall 
be used by the recipients of such grants to provide, under 
the direction and supervision of a licensed medical physi-
cian, free ultrasound examinations to pregnant women 
needing such services. 
(b) ELIGIBILITY REQUIREMENTS.—An entity may re-
ceive a grant under subsection (a) only if the entity meets 
the following conditions: 
(1) The entity is a nonprofit private organiza-
tion that is approved by the Internal Revenue Serv-
ice as a tax-exempt entity under section 501(c)(3) of 
the Internal Revenue Code of 1986. 
(2) The entity operates as a community based 
pregnancy help medical clinic, as defined in sub-
section (f). 
(3) The entity provides medical services to 
pregnant women under the guidance and supervision 
of a physician who serves as the medical director of 
the clinic and is duly licensed to practice medicine 
in the State in which the entity is located. 
(4) The entity is legally qualified to provide 
such medical services to pregnant women and is in
compliance with all Federal, State, and local require-
ments for the provision of such services. 
(5) The entity agrees to comply with the fol-
lowing medical procedures: 
(A) Each pregnant woman upon whom the 
ultrasound equipment is used will be shown the 
visual image of the fetus from the ultrasound 
examination and will be given a general ana-
tomical and physiological description of the 
characteristics of the fetus. 
(B) Each pregnant woman will be given, 
according to the best medical judgment of the 
physician performing the ultrasound examina-
tion or the physician’s agent performing such 
exam, the approximate age of the embryo or 
fetus considering the number of weeks elapsed 
from the probable time of the conception of the 
embryo or fetus, based upon the information 
provided by the client as to the time of her last 
menstrual period, her medical history, a phys-
ical examination, or appropriate laboratory 
tests. 
(C) Each pregnant woman will be given in-
formation on abortion and alternatives to abor-
tion such as childbirth and adoption and infor-
I 
109TH CONGRESS 
1ST SESSION H. R. 1917 
To suspend temporarily the duty on 2,3-Pyridinedicarboxylic acid. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 27, 2005 
Mr. HULSHOF introduced the following bill; which was referred to the 
Committee on Ways and Means 
A BILL 
To suspend temporarily the duty on 2,3-Pyridinedicarboxylic 
acid. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. 2,3-PYRIDINEDICARBOXYLIC ACID. 
(a) IN GENERAL.—Subchapter II of chapter 99 of 
the Harmonized Tariff Schedule of the United States is 
amended by inserting in numerical sequence the following 
new heading: 
‘‘ 
9902.05.62 
2,3-Pyridinedicarboxylic acid 
(CAS No. 89–00–9) (pro-
vided for in subheading 
2933.39.61) .........................
Free 
No change 
No change 
On or before 
12/31/2008 
’’.
(b) EFFECTIVE DATE.—The amendment made by 
subsection (a) applies to goods entered, or withdrawn from 
warehouse for consumption, on or after the 15th day after 
the date of enactment of this Act. 
Æ
mation concerning public and private agencies 
that will assist in those alternatives. 
(D) The entity will obtain and maintain 
medical malpractice insurance in an amount not 
less than $1,000,000, and such insurance will 
cover all activities relating to the use of the 
ultrasound machine purchased with the grant 
under subsection (a). 
(6) The entity does not receive more than 30 
percent of its gross annual revenue from a single 
source or donor. 
(c) LIMITATION ON INDIVIDUAL GRANT AMOUNT.—
No grant under subsection (a) may be made in an amount 
that exceeds an amount equal to 50 percent of the pur-
chase price cost of the ultrasound machine involved, or 
$20,000, whichever is less. 
(d) APPLICATION
FOR GRANT.—A grant may be 
made under subsection (a) only if an application for the 
grant is submitted to the Secretary and the application 
is in such form, is made in such manner, and contains 
such agreements, assurances, and information as the Sec-
retary determines to be necessary to carry out this section. 
(e) ANNUAL REPORT TO SECRETARY.—A grant may 
be made under subsection (a) only if the applicant for the 
grant agrees to report on an annual basis to the Secretary,
in such form and manner as the Secretary may require, 
on the ongoing compliance of the applicant with the eligi-
bility conditions established in subsection (b). 
(f) DEFINITIONS.—For purposes of this Act: 
(1) The term ‘‘community based pregnancy help 
medical clinic’’ means a facility that—
(A) provides free medical services to preg-
nant women under the supervision and direction 
of a licensed physician who serves as the med-
ical director for such clinic; and 
(B) does not charge for any services ren-
dered to its clients, whether or not such services 
are for pregnancy or nonpregnancy related mat-
ters. 
(2) The term ‘‘Secretary’’ means the Secretary 
of Health and Human Services. 
(g) AUTHORIZATION OF APPROPRIATIONS.—For the 
purpose of carrying out this section, there are authorized 
to be appropriated $3,000,000 for fiscal year 2005, and 
such sums as may be necessary for each of the fiscal years 
2006 through 2008.
Æ
176 
ignated decisionmaker for purposes of subpara-
graph (A) with respect to the participants and 
beneficiaries of an employer or plan sponsor, 
whether or not the employer or plan sponsor 
makes such a designation, and shall be deemed 
to have assumed unconditionally all liability of 
the employer or plan sponsor under such des-
ignation in accordance with subsection (o), un-
less the employer or plan sponsor affirmatively 
enters into a contract to prevent the service of 
the designated decisionmaker. 
‘‘(C) TREATMENT
OF
CERTAIN
TRUST 
FUNDS.—For purposes of this paragraph, the 
terms ‘employer’ and ‘plan sponsor’, in connec-
tion with the assumption by a designated deci-
sionmaker of the liability of employer or other 
plan sponsor pursuant to this paragraph, shall 
be construed to include a trust fund maintained 
pursuant to section 302 of the Labor Manage-
ment Relations Act, 1947 (29 U.S.C. 186) or 
the Railway Labor Act (45 U.S.C. 151 et seq.). 
‘‘(19) PREVIOUSLY PROVIDED SERVICES.— 
‘‘(A) IN GENERAL.—Except as provided in 
this paragraph, a cause of action shall not arise 
under paragraph (1) where the denial involved
177 
relates to an item or service that has already 
been fully provided to the participant or bene-
ficiary under the plan or coverage and the claim 
relates solely to the subsequent denial of pay-
ment for the provision of such item or service. 
‘‘(B) EXCEPTION.—Nothing in subpara-
graph (A) shall be construed to— 
‘‘(i) prohibit a cause of action under 
paragraph (1) where the nonpayment in-
volved results in the participant or bene-
ficiary being unable to receive further 
items or services that are directly related 
to the item or service involved in the denial 
referred to in subparagraph (A) or that 
are part of a continuing treatment or se-
ries of procedures; or 
‘‘(ii) limit liability that otherwise 
would arise from the provision of the item 
or services or the performance of a medical 
procedure. 
‘‘(20) EXEMPTION FROM PERSONAL LIABILITY 
FOR INDIVIDUAL MEMBERS OF BOARDS OF DIREC-
TORS, JOINT BOARDS OF TRUSTEES, ETC.—Any indi-
vidual who is—
I 
109TH CONGRESS 
1ST SESSION H. R. 1918 
To suspend temporarily the duty on 80% 2,3-Dimethylbutylnitrile and 20% 
toluene. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 27, 2005 
Mr. HULSHOF introduced the following bill; which was referred to the 
Committee on Ways and Means 
A BILL 
To suspend temporarily the duty on 80% 2,3- 
Dimethylbutylnitrile and 20% toluene. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. 80% 2,3-DIMETHYLBUTYLNITRILE AND 20% TOL-
UENE. 
(a) IN GENERAL.—Subchapter II of chapter 99 of 
the Harmonized Tariff Schedule of the United States is 
amended by inserting in numerical sequence the following 
new heading:
‘‘ 
9902.05.63 
80% 2,3- 
Dimethylbutylnitrile (CAS 
No. 13893–53–3) (provided 
for in subheading 
3824.90.91) and 20% tol-
uene ......................................
Free 
No change 
No change 
On or before 
12/31/2008 
’’. 
(b) EFFECTIVE DATE.—The amendment made by 
subsection (a) applies to goods entered, or withdrawn from 
warehouse for consumption, on or after the 15th day after 
the date of enactment of this Act. 
Æ
I 
109TH CONGRESS 
1ST SESSION H. R. 2170 
To extend the duty suspension on isothiocyanate. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 5, 2005 
Mr. BROWN of South Carolina introduced the following bill; which was 
referred to the Committee on Ways and Means 
A BILL 
To extend the duty suspension on isothiocyanate. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. ISOTHIOCYANATE. 
(a) IN GENERAL.—Heading 9902.01.41 of the Har-
monized Tariff Schedule of the United States (relating to 
isothiocyanate) is amended by striking ‘‘12/31/2006’’ and 
inserting ‘‘12/31/2008’’. 
(b) EFFECTIVE DATE.—The amendment made by 
subsection (a) applies to goods entered, or withdrawn from 
warehouse for consumption, on or after the 15th day after 
the date of the enactment of this Act. 
Æ
178 
‘‘(A) a member of a board of directors of 
an employer or plan sponsor; or 
‘‘(B) a member of an association, com-
mittee, employee organization, joint board of 
trustees, or other similar group of representa-
tives of the entities that are the plan sponsor 
of plan maintained by two or more employers 
and one or more employee organizations; 
shall not be personally liable under this subsection 
for conduct that is within the scope of employment 
or of plan-related duties of the individuals unless the 
individual acts in a fraudulent manner for personal 
enrichment. 
‘‘(o) REQUIREMENTS FOR DESIGNATED DECISION-
MAKERS OF GROUP HEALTH PLANS.— 
‘‘(1) IN GENERAL.—For purposes of subsection 
(n)(18) and section 514(d)(9), a designated decision-
maker meets the requirements of this paragraph 
with respect to any participant or beneficiary if— 
‘‘(A) such designation is in such form as 
may be prescribed in regulations of the Sec-
retary, 
‘‘(B) the designated decisionmaker— 
‘‘(i) meets the requirements of para-
graph (2),
179 
‘‘(ii) assumes unconditionally all liabil-
ity of the employer or plan sponsor in-
volved (and any employee of such employer 
or sponsor acting within the scope of em-
ployment) either arising under subsection 
(n) or arising in a cause of action per-
mitted under section 514(d) in connection 
with actions (and failures to act) of the 
employer or plan sponsor (or employee) oc-
curring during the period in which the des-
ignation under subsection (n)(18) or sec-
tion 514(d)(9) is in effect relating to such 
participant and beneficiary, 
‘‘(iii) agrees to be substituted for the 
employer or plan sponsor (or employee) in 
the action and not to raise any defense 
with respect to such liability that the em-
ployer or plan sponsor (or employee) may 
not raise, and 
‘‘(iv) where paragraph (2)(B) applies, 
assumes unconditionally the exclusive au-
thority under the group health plan to 
make medically reviewable decisions under 
the plan with respect to such participant 
or beneficiary, and
I 
109TH CONGRESS 
1ST SESSION H. R. 1919 
To suspend temporarily the duty on 2,3-Quinolinedicarboxylic acid. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 27, 2005 
Mr. HULSHOF introduced the following bill; which was referred to the 
Committee on Ways and Means 
A BILL 
To suspend temporarily the duty on 2,3-Quinolinedicarboxylic 
acid. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. 2,3-QUINOLINEDICARBOXYLIC ACID. 
(a) IN GENERAL.—Subchapter II of chapter 99 of 
the Harmonized Tariff Schedule of the United States is 
amended by inserting in numerical sequence the following 
new heading: 
‘‘ 
9902.05.64 
2,3-Quinolinedicarboxylic 
acid (CAS No. 643–38–9) 
(provided for in subheading 
2933.49.60) .........................
Free 
No change 
No change 
On or before 
12/31/2008 
’’.
(b) EFFECTIVE DATE.—The amendment made by 
subsection (a) applies to goods entered, or withdrawn from 
warehouse for consumption, on or after the 15th day after 
the date of enactment of this Act. 
Æ
I 
109TH CONGRESS 
1ST SESSION H. R. 2171 
To extend the temporary suspension of duty on Vulkalent E/C. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 5, 2005 
Mr. BROWN of South Carolina introduced the following bill; which was 
referred to the Committee on Ways and Means 
A BILL 
To extend the temporary suspension of duty on Vulkalent 
E/C. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. VULKALENT E/C. 
(a) IN GENERAL.—Heading 9902.38.31 of the Har-
monized Tariff Schedule of the United States (relating to 
Vulkalent E/C) is amended by striking ‘‘12/31/2006’’ and 
inserting ‘‘12/31/2009’’. 
(b) EFFECTIVE DATE.—The amendment made by 
subsection (a) applies to goods entered, or withdrawn from
warehouse for consumption, on or after the 15th day after 
the date of the enactment of this Act. 
Æ
180 
‘‘(C) the designated decisionmaker and the 
participants and beneficiaries for whom the de-
cisionmaker has assumed liability are identified 
in the written instrument required under sec-
tion 402(a) and as required under section 
121(b)(19) of the Patients’ Bill of Rights Act 
of 2005. 
Any liability assumed by a designated decisionmaker 
pursuant to this subsection shall be in addition to 
any liability that it may otherwise have under appli-
cable law. 
‘‘(2) QUALIFICATIONS FOR DESIGNATED DECI-
SIONMAKERS.— 
‘‘(A) IN
GENERAL.—Subject to subpara-
graph (B), an entity is qualified under this 
paragraph to serve as a designated decision-
maker with respect to a group health plan if the 
entity has the ability to assume the liability de-
scribed in paragraph (1) with respect to partici-
pants and beneficiaries under such plan, includ-
ing requirements relating to the financial obli-
gation for timely satisfying the assumed liabil-
ity, and maintains with the plan sponsor and 
the Secretary certification of such ability. Such 
certification shall be provided to the plan spon-
I 
109TH CONGRESS 
1ST SESSION 
H. R. 191 
To amend the Federal Credit Union Act with respect to the limitations 
on member business loans. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 4, 2005 
Mr. ROYCE (for himself and Mr. KANJORSKI) introduced the following bill; 
which was referred to the Committee on Financial Services 
A BILL 
To amend the Federal Credit Union Act with respect to 
the limitations on member business loans. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Faith-Based Lending 
Protection Act’’. 
SEC. 2. MEMBER BUSINESS LOAN EXCLUSION FOR LOANS 
TO NONPROFIT RELIGIOUS ORGANIZATIONS. 
Section 107A(a) of the Federal Credit Union Act (12 
U.S.C. 1757a(a)) is amended by inserting ‘‘, excluding
loans made to nonprofit religious organizations,’’ after 
‘‘total amount of such loans’’. 
Æ
I 
109TH CONGRESS 
1ST SESSION H. R. 2172 
To suspend temporarily the duty on MBTS. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 5, 2005 
Mr. BROWN of South Carolina introduced the following bill; which was 
referred to the Committee on Ways and Means 
A BILL 
To suspend temporarily the duty on MBTS. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. MBTS. 
(a) IN GENERAL.—Subchapter II of chapter 99 of 
the Harmonized Tariff Schedule of the United States is 
amended by inserting in numerical sequence the following 
new heading: 
‘‘ 
9902.06.10 
Mercaptobenzothiazole Di-
sulfide (CAS No. 120–78–5) 
(provided for in subheading 
2934.20.10) .........................
Free 
No change 
No change 
On or before 
12/31/2009 
’’. 
(b) EFFECTIVE DATE.—The amendment made by 
subsection (a) applies to goods entered, or withdrawn from
warehouse for consumption, on or after the 15th day after 
the date of the enactment of this Act. 
Æ
181 
sor or named fiduciary and to the Secretary 
upon designation under subsection (n)(18)(B) 
or section 517(d)(9)(B) and not less frequently 
than annually thereafter, or if such designation 
constitutes a multiyear arrangement, in con-
junction with the renewal of the arrangement. 
‘‘(B) SPECIAL
QUALIFICATION
IN
THE 
CASE OF CERTAIN REVIEWABLE DECISIONS.—In 
the case of a group health plan that provides 
benefits consisting of medical care to a partici-
pant or beneficiary only through health insur-
ance coverage offered by a single health insur-
ance issuer, such issuer is the only entity that 
may be qualified under this paragraph to serve 
as a designated decisionmaker with respect to 
such participant or beneficiary, and shall serve 
as the designated decisionmaker unless the em-
ployer or other plan sponsor acts affirmatively 
to prevent such service. 
‘‘(3) REQUIREMENTS RELATING TO FINANCIAL 
OBLIGATIONS.—For purposes of paragraph (2)(A), 
the requirements relating to the financial obligation 
of an entity for liability shall include— 
‘‘(A) coverage of such entity under an in-
surance policy or other arrangement, secured
I 
109TH CONGRESS 
1ST SESSION H. R. 1920 
To suspend temporarily the duty on p-Chlorophenylglycine. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 27, 2005 
Mr. HULSHOF introduced the following bill; which was referred to the 
Committee on Ways and Means 
A BILL 
To suspend temporarily the duty on p-Chlorophenylglycine. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. P-CHLOROPHENYLGLYCINE. 
(a) IN GENERAL.—Subchapter II of chapter 99 of 
the Harmonized Tariff Schedule of the United States is 
amended by inserting in numerical sequence the following 
new heading: 
‘‘ 
9902.05.65 
p-Chlorophenylglycine (CAS 
No. 6212–33–5) (provided 
for in subheading 
2922.49.30) .........................
Free 
No change 
No change 
On or before 
12/31/2008 
’’. 
(b) EFFECTIVE DATE.—The amendment made by 
subsection (a) applies to goods entered, or withdrawn from
warehouse for consumption, on or after the 15th day after 
the date of enactment of this Act. 
Æ